Matthew Hamilton Rosenberg’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-726
| Closed | -$54.9K | – | 807 |
|
|
2026
Q1 | $54.9K | Hold |
726
| – | – | 0.01% | 410 |
|
|
2025
Q4 | $54.1K | Hold |
726
| – | – | 0.01% | 412 |
|
|
2025
Q3 | $49K | Hold |
726
| – | – | 0.01% | 424 |
|
|
2025
Q2 | $47.3K | Hold |
726
| – | – | 0.01% | 449 |
|
|
2025
Q1 | $44.8K | Hold |
726
| – | – | 0.01% | 439 |
|
|
2024
Q4 | $52.3K | Hold |
726
| – | – | 0.01% | 414 |
|
|
2024
Q3 | $59.1K | Hold |
726
| – | – | 0.02% | 397 |
|
|
2024
Q2 | $53.8K | Hold |
726
| – | – | 0.02% | 407 |
|
|
2024
Q1 | $55.3K | Hold |
726
| – | – | 0.02% | 414 |
|
|
2023
Q4 | $51.9K | Hold |
726
| – | – | 0.02% | 428 |
|
|
2023
Q3 | $50.4K | Hold |
726
| – | – | 0.02% | 418 |
|
|
2023
Q2 | $58.8K | Buy |
726
+1
| +0.1% | +$82 | 0.02% | 400 |
|
|
2023
Q1 | $58.5K | Hold |
725
| – | – | 0.02% | 432 |
|
|
2022
Q4 | $54.2K | Hold |
725
| – | – | 0.02% | 438 |
|
|
2022
Q3 | $47K | Buy |
725
+6
| +0.8% | +$416 | 0.02% | 453 |
|
|
2022
Q2 | $50K | Hold |
719
| – | – | 0.02% | 458 |
|
|
2022
Q1 | $55K | Buy |
+719
| New | +$51.7K | 0.02% | 444 |
|
Other funds holding HOLX
Matthew Hamilton Rosenberg's HOLX Position: Q2 2026 in Review
Matthew Hamilton Rosenberg sold out of Hologic (HOLX) in Q2 2026, closing a stake of 726 shares — an estimated $54.9K sold.
Matthew Hamilton Rosenberg first reported a position in HOLX in Q1 2022 and held it in 17 quarters. The position peaked at $59.1K in Q3 2024. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.
- Matthew Hamilton Rosenberg reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
- Matthew Hamilton Rosenberg sold 726 Hologic shares in Q2 2026, an estimated $54.9K.
- Matthew Hamilton Rosenberg first reported a position in Hologic in Q1 2022 and held it in 17 quarters.
- Matthew Hamilton Rosenberg's Hologic position peaked at $59.1K in Q3 2024.
- 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.
Based on Matthew Hamilton Rosenberg's 13F filing for Q2 2026, filed 17 Jul 2026.